Trivalent arsenic (arsenite) is a human carcinogen. However, the molecular mechanism of arsenite-induced carcinogenesis is still not well understood. In this study, we found that arsenite induced translocation of PKCε, PKCδ, and PKCα from cytosol to membranes. Rottlerin, a selective inhibitor for PKCδ, and safingol, a specific inhibitor for PKCα, both markedly inhibited arsenite-induced AP-1 activity. These inhibitory effects by rottlerin and safingol appeared to be dose dependent. Arsenite-induced phosphorylation of Erks was inhibited by rottlerin, while safingol inhibited arsenite-induced phosphorylation of JNKs and p38 kinases. Dominant negative mutant transfectant of PKCε markedly blocked arsenite-induced AP-1 activity and the phosphorylation of Erks, JNKs, and p38 kinases. These data demonstrate that PKCδ, PKCε, and PKCα mediate arsenite-induced AP-1 activation in JB6 cells through different MAP kinase (Erks, JNKs, and p38 kinases) pathways.
|Original language||English (US)|
|Number of pages||9|
|Journal||Journal of Environmental Pathology, Toxicology and Oncology|
|State||Published - 2000|
- MAP kinase